Cargando…
Oral antiviral treatments for COVID-19: opportunities and challenges
The use of antiviral COVID-19 medications can successfully inhibit SARS-CoV-2 replication and prevent disease progression to a more severe form. However, the timing of antiviral treatment plays a crucial role in this regard. Oral antiviral drugs provide an opportunity to manage SARS-CoV-2 infection...
Autores principales: | Rahmah, Laila, Abarikwu, Sunny O., Arero, Amanuel Godana, Essouma, Mickael, Jibril, Aliyu Tijani, Fal, Andrzej, Flisiak, Robert, Makuku, Rangarirai, Marquez, Leander, Mohamed, Kawthar, Ndow, Lamin, Zarębska-Michaluk, Dorota, Rezaei, Nima, Rzymski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309032/ https://www.ncbi.nlm.nih.gov/pubmed/35871712 http://dx.doi.org/10.1007/s43440-022-00388-7 |
Ejemplares similares
-
Correction: Oral antiviral treatments for COVID-19: opportunities and challenges
por: Rahmah, Laila, et al.
Publicado: (2022) -
Updates in Management of SARS-CoV-2 Infection
por: Flisiak, Robert, et al.
Publicado: (2022) -
Prognostic Potential of the Controlling Nutritional Status (CONUT) Score in Predicting All-Cause Mortality and Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Meta-Analysis
por: Arero, Godana, et al.
Publicado: (2022) -
Borderless collaboration is needed for COVID-19—A disease that knows no borders
por: Mohamed, Kawthar, et al.
Publicado: (2020) -
International Efforts to Save Healthcare Personnel during COVID-19
por: Mohamed, Kawthar, et al.
Publicado: (2020)